Detail Information
Publications
Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccineF Marc LaForce
Program for Appropriate Technology in Health, in Washington, DC, USA
Health Aff (Millwood) 30:1049-57. 2011..The vaccine's low cost--less than fifty cents per dose--makes it possible for the affected countries themselves to purchase vaccines for future birth cohorts...
The Meningitis Vaccine ProjectF Marc LaForce
The Meningitis Vaccine Project, PATH, 13 Chemin du Levant, 01210 Ferney Voltaire, France
Vaccine 25:A97-100. 2007..The MVP model is a clear example of the usefulness of a "push mechanism" to finance the development of a needed vaccine for the developing world...
